MAXHEALTH - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.6
| Stock Code | MAXHEALTH | Market Cap | 96,916 Cr. | Current Price | 996 ₹ | High / Low | 1,314 ₹ |
| Stock P/E | 133 | Book Value | 91.9 ₹ | Dividend Yield | 0.15 % | ROCE | 10.5 % |
| ROE | 8.46 % | Face Value | 10.0 ₹ | DMA 50 | 1,017 ₹ | DMA 200 | 1,057 ₹ |
| Chg in FII Hold | -5.16 % | Chg in DII Hold | 5.12 % | PAT Qtr | 203 Cr. | PAT Prev Qtr | 200 Cr. |
| RSI | 42.4 | MACD | 4.46 | Volume | 26,70,620 | Avg Vol 1Wk | 50,16,210 |
| Low price | 903 ₹ | High price | 1,314 ₹ | PEG Ratio | 80.6 | Debt to equity | 0.09 |
| 52w Index | 22.5 % | Qtr Profit Var | 14.6 % | EPS | 7.36 ₹ | Industry PE | 47.0 |
📊 Analysis:
Max Healthcare (MAXHEALTH) is trading at ₹996, below both its 50 DMA (₹1,017) and 200 DMA (₹1,057), reflecting short-term and medium-term weakness. RSI at 42.4 indicates subdued momentum, while MACD at 4.46 shows mild bullish bias. Current volume (26.7 lakh) is significantly below the weekly average (50.1 lakh), suggesting weaker intraday participation. Valuations are extremely stretched (P/E 133 vs industry 47), with weak ROE (8.46%) and ROCE (10.5%). Fundamentals remain modest despite profit growth, making MAXHEALTH a speculative intraday candidate requiring strict discipline.
💡 Optimal Buy Zone:
₹990–₹1,000 if price sustains above VWAP and intraday support.
🎯 Exit Levels:
- Profit-taking: ₹1,020–₹1,030 (near short-term resistance).
- Stop-loss: ₹975–₹980 (below intraday support).
⏱️ Intraday Exit Strategy:
If already holding, consider exiting when
- RSI dips below 41 intraday.
- Price fails to hold above ₹990 support.
- Volume remains weak (<30 lakh) with stagnating price action.
---
### ✅ Positive
- PAT growth (₹200 Cr. → ₹203 Cr.) shows operational improvement.
- EPS at ₹7.36 reflects earnings stability.
- DII holdings increased (+5.12%), showing strong domestic support.
- Debt-to-equity ratio at 0.09, low leverage.
### ⚠️ Limitation
- Extremely high valuation (P/E 133 vs industry 47).
- Weak ROE (8.46%) and ROCE (10.5%).
- PEG ratio at 80.6, poor valuation-to-growth alignment.
- Volume below weekly average, limiting intraday strength.
### 📉 Company Negative News
- FII holdings decreased (-5.16%), showing reduced foreign investor confidence.
- Stock trading below both DMA 50 and DMA 200.
### 📈 Company Positive News
- Quarterly profit growth of 14.6%.
- DII accumulation (+5.12%) reflects domestic investor confidence.
### 🏭 Industry
- Healthcare sector average P/E at 47, Max Healthcare trades at a steep premium (133).
- Sector outlook supported by rising demand for healthcare services and hospital expansion.
### 📌 Conclusion
Max Healthcare is a speculative intraday candidate with valuation risks but modest profit growth. Best suited for cautious trades near ₹990–₹1,000 with exits around ₹1,020–₹1,030. Maintain strict stop-loss discipline below ₹980 to protect against intraday reversals.
This positions MAXHEALTH as a speculative intraday trade with stretched valuations but tactical opportunities near support. Would you like me to extend this into a swing trade setup with medium-term entry/exit zones and sector overlays?